what is glp-1 for Can one drug do it all? Reviewing the expanding clinical universe of agonists GLP-1 Agonists in Cardiovascular Diseases:

GLP-1RAs also lower the risk of stroke by reducing traditional stroke risk factors including hyperglycemia, hypertension, and dyslipidemia

In mice, both chronic and acute alcohol decreased NTS1 and NTS2 in the NAc and midbrain (Campbell and Gene Erwin, Neurotensin receptor type 1 and alcohol Since NTS1 inhibits D2R function and potentially regulates glutamate signaling, NTS1 is a promising therapeutic target for AUD

The dosage is based on your medical condition and response to therapy

Three phases of detoxification:[ref] Phase I (bioactivation transformation) involves breaking apart large toxins and converting them into polar molecules